What is Orexin B?
Orexin B — also called Hypocretin-2 (Hcrt-2) — is a small protein-like signaling molecule (a neuropeptide) made in a tiny region deep in the brain called the hypothalamus. It is one of two closely related peptides in the orexin family; its sibling is Orexin A (Hypocretin-1). Together, they act as the brain's built-in "stay awake" system, helping maintain alertness, regulate feeding, and coordinate dozens of other body functions.[1]
Both peptides were discovered in the late 1990s and generated immediate scientific excitement when researchers found that losing the neurons that produce them causes narcolepsy — a disorder where the brain can't reliably stay awake or stay asleep.[1] Orexin B is classified as a research compound and is not approved for human therapeutic use. Everything on this page reflects preclinical and early clinical science only.
How Orexin B Works
Think of Orexin B as a key, and its receptors as locks on the surface of brain cells. There are two locks: OX1R and OX2R. Orexin A fits both locks fairly well. Orexin B strongly prefers the OX2R lock.[1] When Orexin B slots into OX2R, it triggers a cascade of signals inside the cell — through what are called G-protein-coupled pathways — that ultimately tells the neuron to fire and stay active.[2]
OX2R is found all over the brain, especially in areas that control whether you are awake or asleep. This is why OX2R is considered the primary "sleep-wake switch" receptor, while OX1R plays a bigger role in motivation and the body's autonomic responses (things like heart rate and stress reactions).[1] Because Orexin B targets OX2R so selectively, scientists use it as a precise tool to probe exactly what the OX2R side of the system is doing — without stirring up OX1R effects at the same time.
What the Research Shows
Sleep and Wakefulness
The clearest story in the research is that OX2R, activated by Orexin B, is a critical controller of sleep-wake boundaries. Studies show that when you block OX2R signaling in specific brain circuits, animals shift how they cycle between sleep stages.[1] A 2025 study published in Cell Reports found something nuanced: OX2R is expressed on a class of neurons called MCH (melanin-concentrating hormone) neurons, which actually have the opposite job to orexin neurons — they promote sleep rather than wakefulness. When researchers applied Orexin B to brain slices, it triggered both excitatory and inhibitory responses in different subgroups of MCH neurons. When OX2R was knocked out of those neurons, transitions from deep (NREM) sleep into REM sleep were reduced, and the animals also developed metabolic problems including impaired insulin sensitivity.[3] This tells us that Orexin B's influence on sleep isn't a simple on/off switch — it's more like a complex mixing board.
Beyond Sleep: Metabolism and Feeding
That same 2025 research showed that disrupting OX2R signaling in MCH neurons led to excessive feeding after fasting and worse insulin sensitivity in female mice.[3] This hints that Orexin B's reach extends well beyond regulating when you feel sleepy — it appears to intertwine sleep quality with how the body handles energy and blood sugar.
Pain Signaling (Nociception)
A 2002 electrophysiology study recorded the electrical activity of individual spinal cord neurons called superficial dorsal horn (SDH) cells — the neurons that first process pain and temperature signals coming in from the body. When Orexin B was applied, it excited certain SDH neurons and increased inhibitory signaling among them. The authors interpreted this as evidence that Orexin B helps the brain orchestrate arousal-related responses that include pain and temperature perception.[6]
Heart Protection
Research has also uncovered Orexin B receptors — specifically OX2R — directly on heart muscle cells. Animal and human heart tissue studies found that Orexin B, acting through OX2R, enhances the strength of heart muscle contractions and activates protective signaling proteins (ERK1/2 and Akt). A negative correlation was observed between OX2R expression and the clinical severity of heart failure symptoms, raising interest in OX2R as a possible cardiovascular research target.[4]
Drug Development Context
The flip side of this science is that blocking orexin receptors helps people sleep. Three FDA-approved insomnia drugs — suvorexant, lemborexant, and daridorexant — work by blocking both OX1R and OX2R to dampen the brain's arousal drive. Researchers are now testing selective OX2R agonists (compounds that mimic Orexin B) as treatments for narcolepsy, where the orexin system is underactive.[5] Understanding exactly how Orexin B behaves is foundational to all of this work.
What Orexin B Is Being Studied For
- Narcolepsy and disorders of excessive daytime sleepiness (via OX2R agonism)[1]
- REM sleep regulation and sleep-stage transitions[3]
- Metabolic disorders and insulin sensitivity[3]
- Cardiovascular protection and heart failure models[4]
- Pain and sensory processing at the spinal cord level[6]
- Mapping the precise roles of OX1R versus OX2R in brain circuitry[2]
How Orexin B Is Dosed in Research
Because Orexin B is a research-use-only peptide studied exclusively in preclinical (cell and animal) settings, there are no standardized human dosing guidelines. Research quantities, concentrations, and administration routes vary widely depending on the experimental model — from nanomolar concentrations applied directly to brain slices[6] to in vivo infusions in rodents. For a structured overview of the concentrations reported across published studies, refer to the dosage chart on this page, and use the calculator to work out solution concentrations for your specific research application. Always follow your institution's protocols and applicable regulations.
Mixing and Storing Orexin B
Orexin B is a peptide, which means it is sensitive to heat, repeated freeze-thaw cycles, and harsh pH levels. For research use, it is typically supplied as a lyophilized (freeze-dried) powder. To reconstitute, add sterile water or a suitable aqueous buffer (such as PBS or acetic acid solution, depending on the supplier's guidance) slowly to the vial, swirling gently — never shake vigorously, as this can break the peptide's structure. Once dissolved, divide the solution into single-use aliquots to avoid repeated freezing and thawing. Store lyophilized powder at −20 °C or colder; store reconstituted aliquots at −80 °C and use within a few weeks. Allow aliquots to reach room temperature naturally before use. Always check your supplier's specific storage and stability data sheet, as formulations can differ.
Sources
- Hypocretin/Orexin Receptor Pharmacology and Sleep Phases. — Frontiers of neurology and neuroscience, 2021. PMID 34052813.
- Orexin/Hypocretin Signaling. — Current topics in behavioral neurosciences, 2017. PMID 27909990.
- Orexin/hypocretin receptor 2 signaling in MCH neurons regulates REM sleep and insulin sensitivity. — Cell reports, 2025. PMID 39946231.
- Role of Orexin-B/Orexin 2 receptor in myocardial protection. — Clinical science (London, England : 1979), 2019. PMID 30948623.
- Targeting the Orexin System in the Pharmacological Management of Insomnia and Other Diseases: Suvorexant, Lemborexant, Daridorexant, and Novel Experimental Agents. — International journal of molecular sciences, 2025. PMID 40943625.
- Hypocretin-2 (orexin-B) modulation of superficial dorsal horn activity in rat. — The Journal of physiology, 2002. PMID 11790816.
EN
BR
ES
FR
DE
RU